Medium chain acyl-CoA dehydrogenase deficiency ("MCADD") is a rare genetic metabolic disorder. It is a type of fatty acid oxidation disorder. MCADD is estimated to affect one (1) in every seventeen thousand (17,000) people.
Newborn screening in the United States dates back to the early 1960s. Before this time, the focus on infant mortality related primarily to diarrheal diseases, influenza, and other infectious diseases.
I recently received a phone call from Whittney LaHayne, head varsity volleyball coach at Banks County High School in Homer, Georgia. Coach LaHayne and I had an immediate connection….we both have a son with MCADD. She reached out to me and explained that each year her volleyball team hosts a fundraiser to support a cause. […]
